| Autor: |
Ilonze OJ; Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, USA. Email: oilonze@iu.edu., Hicks A; Division of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Atanda B; Winchester Cardiology and Vascular Medicine, Winchester, VA, USA., Abdou MH; Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Onyekwelu C; Department of Cardiology, Norton Healthcare, Louisville, KY, USA., Chukwu E; Department of Cardiology, Baylor Scott and White, Temple, TX, USA., Karaye KM; Department of Medicine, Aminu Kano Teaching Hospital; Department of Medicine, Bayero University, Kano, Nigeria., Katibi I; University of Ilorin, PMB 1515; University of Ilorin Teaching Hospital, Ilorin, Nigeria., Ogah OS; Division of Cardiology, Department of Medicine, University College Hospital, Ibadan, Nigeria., Emerole O; Division of Cardiology, Department of Internal Medicine, Atrium Health Navicent, Macon, GA, USA., Ajuluchukwu JN; Department of Medicine, Division of Cardiology, University of Lagos, Lagos, Nigeria., Sani MU; Department of Medicine, Aminu Kano Teaching Hospital; Department of Medicine, Bayero University, Kano, Nigeria., Asuzu CC; Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Ogunniyi MO; Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. |
| Abstrakt: |
The Nigerian Cardiovascular Symposium is an annual conference held in partnership with cardiologists in Nigeria and the diaspora to provide updates in cardiovascular medicine and cardiothoracic surgery with the aim of optimising cardiovascular care for the Nigerian population. This virtual conference (due to the COVID-19 pandemic) has created an opportunity for effective capacity building of the Nigerian cardiology workforce. The objective of the conference was for experts to provide updates on current trends, clinical trials and innovations in heart failure, selected cardiomyopathies such as hypertrophic cardiomyopathy and cardiac amyloidosis, pulmonary hypertension, cardiogenic shock, left ventricular assist devices and heart transplantation. Furthermore, the conference aimed to equip the Nigerian cardiovascular workforce with skills and knowledge to optimise the delivery of effective cardiovascular care, with the hope of curbing 'medical tourism' and the current 'brain drain' in Nigeria. Challenges to optimal cardiovascular care in Nigeria include workforce shortage, limited capacity of intensive care units, and availability of medications. This partnership represents a key first step in addressing these challenges. Future action items include enhanced collaboration between cardiologists in Nigeria and the diaspora, advancing participation and enrollment of African patients in global heart failure clinical trials, and the urgent need to develop heart failure clinical practice guidelines for Nigerian patients. |
